What is Azoximer bromide?
{{Infobox drug | drug_name = | IUPAC_name = <nowiki>Poly[[1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide]ethylene- co-[(piperazin-1,4-diyl 1-oxide)ethylene]]</nowiki> | image = Azoximer bromide.svg | width = 250 | alt = | caption = <!-- Clinical data --> | tradename = | Drugs.com = | MedlinePlus = | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category= | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | legal_status = | routes_of_administration = <!-- Pharmacokinetic data --> | bioavailability = up to 89% | protein_bound = | metabolism = | elimination_half-life = 25.4 hours (intravenous routes) | excretion = <!-- Identifiers --> | CAS_number = 892497-01-7 | ATCvet = | ATC_prefix = L | ATC_suffix = 03AX | PubChem = | DrugBank = | synonyms = Polyoxidonium, Synpol | ChemSpiderID = none <!-- Chemical data --> | chemical_formula = <nowiki>[[</nowiki>C<sub>8</sub>H<sub>15</sub>BrN<sub>2</sub>O<sub>2</sub>]<sub>x</sub>[C<sub>6</sub>H<sub>12</sub>N<sub>2</sub>O]<sub>y</sub>]<sub>n</sub> | molecular_weight = 60000–100000 g/mol }} '''Azoximer bromide''' is a [[Macromolecule|macromolecular]] compound with high-molecular weight and not proved immunomodulating activity. It is using in CIS countries for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative. Azoximer bromide is sold under the trade name '''Polyoxidonium'''. Polyoxidonium is registered in US Patent-5503830 from 1996,<ref>http://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq=US+5503830</ref><ref>http://www.wikipatents.com/US-Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use-thereo